Publication Highlights in Recent Years
Turjanmaa E, Kaunisto H, Kemppainen E, Nilsson N, Hervonen K, Mankki I, Jernman J, Saavalainen P, Lempainen J, Alakoski A, De Leo L, Ziberna F, Reunala T, Kaukinen K, Lindfors K, Salmi T. Dermal IgA Is Rare in Celiac Disease and Relatives and Lacks Dermatitis Herpetiformis-Type Colocalization with Transglutaminase 3. J Invest Dermatol 2025: S0022-202X(25)03415-3. doi: 10.1016/j.jid.2025.09.380.
Mäkinen J, Heikkilä P, Pajula J, El Mekkaoui K, Størdal K, Lindfors K, Laiho JE, Ranta J, Rökman J, Hyöty H, Emmert-Streib F, Kurppa K, Kivelä L; HEDIMED Investigator Group. Screening for Celiac Disease in Childhood: Cost-effectiveness of Multiple Genetic and Serological Testing Approaches. Clin Gastroenterol Hepatol 2025: S1542-3565(25)01032-8. doi: 10.1016/j.cgh.2025.11.030.
Nurmi R, Turunen Beteta C, Kurppa K, Huhtala H, Lindfors K, Kivelä L, Kaukinen K, Paavola S. Low positive and borderline negative transglutaminase antibody levels are frequently associated with a coeliac disease diagnosis. J Intern Med 2025; 298(6):617-625. doi: 10.1111/joim.70025.
Dotsenko V, Tewes B, Hils M, Pasternack R, Isola J, Taavela J, Popp A, Sarin J, Huhtala H, Hiltunen P, Zimmermann T, Mohrbacher R, Greinwald R, Lundin KEA, Schuppan D, Mäki M, Viiri K; CEC-3 Investigators. Transcriptomic analysis of intestine following administration of a transglutaminase 2 inhibitor to prevent gluten-induced intestinal damage in celiac disease. Nat Immunol 2024; 25(7):1218-1230. doi: 10.1038/s41590-024-01867-0.
Taavela J, Kurppa K, Jääskeläinen T, Kaartinen NE, Rissanen H, Huhtala H, Mäki M, Kaukinen K. Trends in the prevalence rates and predictive factors of coeliac disease: A long-term nationwide follow-up study. Aliment Pharmacol Ther 2024; 59(3):372-379. doi: 10.1111/apt.17803.
Kurppa K, Mulder CJ, Stordal K, Kaukinen K. Celiac Disease Affects 1% of Global Population: Who Will Manage All These Patients? Gastroenterology 2024;167(1):148-158. doi: 10.1053/j.gastro.2023.12.026.
Peltola M, Kaukinen K, Basnyat P, Raitanen J, Haimila K, Liimatainen S, Rainesalo S, Peltola J. Hippocampal sclerosis is associated with celiac disease type immunity in patients with drug-resistant temporal lobe epilepsy. J Neurol 2024;271(5):2596-2604. doi: 10.1007/s00415-024-12210-w.
Nilsson N, Leivo J, Collin P, Koskinen I, Kaukinen K, Huhtala H, Palmio J, Reunala T, Hervonen K, Salmi T, Pasternack C. Risk of vascular diseases in patients with dermatitis herpetiformis and coeliac disease: a long-term cohort study. Ann Med 2023; 55(1):2227423. doi: 10.1080/07853890.2023.2227423.
Nurmi R, Pasternack C, Salmi T, Hervonen K, Koskinen I, Järvelin J, Huhtala H, Collin P, Mustonen J, Kaukinen K, Mäkelä S. The risk of renal comorbidities in celiac disease patients depends on the phenotype of celiac disease. J Intern Med 2022; 292(5):779-787. doi: 10.1111/joim.13532.
Repo M, Kurppa K, Huhtala H, Luostarinen L, Kaukinen K, Kivelä L. Significance of low ferritin without anaemia in screen-detected, adult coeliac disease patients. J Intern Med 2022; 292(6):904-914. doi: 10.1111/joim.13548.
Schiepatti A, Sanders DS, Baiardi P, Caio G, Ciacci C, Kaukinen K, Lebwohl B, Leffler D, Malamut G, Murray JA, Rostami K, Rubio-Tapia A, Volta U, Biagi F. Nomenclature and diagnosis of seronegative coeliac disease and chronic non-coeliac enteropathies in adults: the Paris consensus. Gut 2022; 71(11):2218-2225. doi: 10.1136/gutjnl-2021-326645
Schuppan D*, Mäki M*, Lundin KEA, Isola J, Friesing-Sosnik T, Taavela J, Popp A, Koskenpato J, Langhorst J, Hovde Ø, Lähdeaho ML, Fusco S, Schumann M, Török HP, Kupcinskas J, Zopf Y, Lohse AW, Scheinin M, Kull K, Biedermann L, Byrnes V, Stallmach A, Jahnsen J, Zeitz J, Mohrbacher R, Greinwald R; CEC-3 Trial Group. A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease. N Engl J Med. 2021; 385(1):35-45. doi: 10.1056/NEJMoa2032441
Kivelä L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol 2021; 18(3):181-195. doi: 10.1038/s41575-020-00378-1
Paavola S, Lindfors K, Kivelä L, Cerqueira J, Huhtala H, Saavalainen P, Tauschi R, Kaukinen K, Kurppa K. Presence of high-risk HLA genotype is the most important individual risk factor for coeliac disease among at-risk relatives. Aliment Pharmacol Ther 2021;54(6):805-813.
Cerqueira JXM, Saavalainen P, Kurppa K, Laurikka P, Huhtala H, Nykter M, L E Koskinen L, Yohannes DA, Kilpeläinen E, Shcherban A, Palotie A, Kaukinen K, Lindfors K. Independent and cumulative coeliac disease-susceptibility loci are associated with distinct disease phenotypes. J Hum Genet 2021; 66(6):613-623. doi: 10.1038/s10038-020-00888-5.
Dotsenko V, Oittinen M, Taavela J, Popp A, Peräaho M, Staff S, Sarin J, Leon F, Isola J, Mäki M, Viiri K. Genome-Wide Transcriptomic Analysis of Intestinal Mucosa in Celiac Disease Patients on a Gluten-Free Diet and Postgluten Challenge. Cell Mol Gastroenterol Hepatol 2021; 11(1):13-32. doi: 10.1016/j.jcmgh.2020.07.010
Lindfors K, Lin J, Lee HS, Hyöty H, Nykter M, Kurppa K, Liu E, Koletzko S, Rewers M, Hagopian W, Toppari J, Ziegler AG, Akolkar B, Krischer JP, Petrosino JF, Lloyd RE, Agardh D; TEDDY Study Group. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study. Gut 2020; 69(8):1416-1422. doi: 10.1136/gutjnl-2019-319809.
Kalliokoski S, Mansikka E, de Kauwe A, Huhtala H, Saavalainen P, Kurppa K, Hervonen K, Reunala T, Kaukinen K, Salmi T, Lindfors K. Gliadin-Induced Ex Vivo T-Cell Response in Dermatitis Herpetiformis: A Predictor of Clinical Relapse on Gluten Challenge? J Invest Dermatol 2020; 140(9):1867-1869.e2. doi: 10.1016/j.jid.2019.12.038.
Virta J, Hannula M, Tamminen I, Lindfors K, Kaukinen K, Popp A, Taavela J, Saavalainen P, Hiltunen P, Hyttinen J, Kurppa K. X-ray microtomography is a novel method for accurate evaluation of small-bowel mucosal morphology and surface area. Sci Rep 2020;10(1):13164. doi: 10.1038/s41598-020-69487-w.
Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, Shamir R, Troncone R, Auricchio R, Castillejo G, Christensen R, Dolinsek J, Gillett P, Hróbjartsson A, Koltai T, Maki M, Nielsen SM, Popp A, Størdal K, Werkstetter K, Wessels M. European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020. J Pediatr Gastroenterol Nutr 2020; 70(1):141-156. doi: 10.1097/MPG.0000000000002497.
Koskinen I, Virta LJ, Huhtala H, Ilus T, Kaukinen K, Collin P. Overall and Cause-Specific Mortality in Adult Celiac Disease and Dermatitis Herpetiformis Diagnosed in the 21st Century. Am J Gastroenterol 2020; 115(7):1117-1124. doi: 10.14309/ajg.0000000000000665.
Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, Murray JA, Verdu EF, Kaukinen K. Coeliac disease. Nat Rev Dis Primers 2019; 5(1):3. doi: 10.1038/s41572-018-0054-z.
Fuchs V, Kurppa K, Huhtala H, Laurila K, Mäki M, Collin P, Salmi T, Luostarinen L, Saavalainen P, Kaukinen K. Serology-based criteria for adult coeliac disease have excellent accuracy across the range of pre-test probabilities. Aliment Pharmacol Ther 2019; 49(3):277-284. doi: 10.1111/apt.15109.
Mansikka E, Hervonen K, Kaukinen K, Ilus T, Oksanen P, Lindfors K, Laurila K, Hietikko M, Taavela J, Jernman J, Saavalainen P, Reunala T, Salmi T. Gluten Challenge Induces Skin and Small Bowel Relapse in Long-Term Gluten-Free Diet-Treated Dermatitis Herpetiformis. J Invest Dermatol 2019; 139(10):2108-2114. doi: 10.1016/j.jid.2019.03.1150.